ng-nitroarginine methyl ester has been researched along with Coronary Occlusion in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Britto, LR; Couto, GK; Mill, JG; Rossoni, LV | 1 |
1 other study(ies) available for ng-nitroarginine methyl ester and Coronary Occlusion
| Article | Year |
|---|---|
Enhanced nitric oxide bioavailability in coronary arteries prevents the onset of heart failure in rats with myocardial infarction.
Topics: Acetylcholine; Animals; Biological Availability; Coronary Occlusion; Coronary Vessels; Endothelium, Vascular; Heart Failure; Humans; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Rats; Vasodilation; Vasodilator Agents | 2015 |